Kira Bona is an Oncology physician affiliated with Boston Children's Hospital. OpenAlex indexes 185 publications with 2,545 citations (h-index 29); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
450 Brookline Ave
Dana 1160
Boston, MA 022155418
Telephone
617-632-4688Registry record last updated 21 Apr 2015.
Clinical trials
- Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Sponsor: Dana-Farber Cancer Institute
- PediCARE Health Equity Intervention in High-Risk Neuroblastoma
Sponsor: Dana-Farber Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Servier Pharmaceuticals LLCProgram year20221 payment
- SERVIER PHARMACEUTICALS LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
3 NIH research awards on record, funded 2016–2023 per NIH RePORTER. The latest:
- Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress
Dana-Farber Cancer Inst
FY2023$797,728R01CA267107 - Novel Health Equity Intervention to Improve Pediatric Oncology Outcome Disparities: Targeting Poverty and Psychosocial Stress
Dana-Farber Cancer Inst
FY2022$651,395R01CA267107 - A Preventive Care Approach to Mitigate the Impact of Pediatric ALL Treatment on Sleep
Dana-Farber Cancer Inst
FY2022$89,000R03CA259894
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease
Journal of Clinical Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Stuart Orkin, MD
Boston Children's Hospital
Jane Newburger, MD
Boston Children's Hospital
Michael Landzberg, MD
Boston Children's Hospital
Stephen Sallan, MD
Boston Children's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”